Research programme: prophylactic anti-infective vaccines - Hilleman Laboratories

Drug Profile

Research programme: prophylactic anti-infective vaccines - Hilleman Laboratories

Alternative Names: Cholera vaccine - Hilleman Laboratories; ETEC vaccine; HSRV - Hilleman Laboratories; Low-cost men ACYWX conjugate vaccine

Latest Information Update: 07 Apr 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator MSD Wellcome Trust Hilleman Laboratories
  • Class Bacterial vaccines; Cholera vaccines; Escherichia coli vaccines; Meningococcal vaccines; Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Meningococcal infections
  • Research Escherichia coli infections
  • No development reported Cholera

Most Recent Events

  • 30 Mar 2017 MSD Wellcome Trust Hilleman Laboratories and Institute of Cholera and Enteric Diseases (NICED), India sign a Memorandum of Understanding to jointly develop vaccines for diarrhoeal diseases
  • 16 Jul 2016 No recent reports of development identified for research development in Cholera(Prevention) in India (PO)
  • 10 Apr 2016 Early research in Escherichia coli infections (Prevention) in India (PO) before April 2016 (Hilleman Laboratories website, April 2016)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top